equityflowunderstand the flow and follow it
EquityFlow › Companies › BioPhenoMA

BioPhenoMA

Biotech · Tokyo, JP

Waseda spinout developing ultra-sensitive protein biomarker detection (TN-cyclon) for cancer/neuro diseases

Funding history

DateRoundAmount
Nov 2024Seed
BioPhenoMA, a Waseda University spinout developing ultra-sensitive protein-biomarker assays, raised about 190M JPY in a pre-Series A from Waseda University Ventures and JMTC Capital.
$1.2M

Investors

Tap an investor to see what else they have backed.

JMTC CapitalWaseda University Ventures

Other companies in Biotech

ImperagenHaga BiosciencePixelgen TechnologiesGallantChai DiscoverySNIPR BiomeCellbox LabsScope BiosciencesGenLuminaActitheraNUCLIDIUMAnocca

Other companies in JP

PayPayRapidusMWAracanSmart CraftHerLifeLabTokenzDubGuildDJ InsightSnack TechnologiesNekonomeLinQ

Other companies at Seed stage

&Open(Re)vive1-2-Taste100% Livre1000 Satellites100ms10club10pct.10x Science10x.team123Projetei150 Minuten
Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.